Bovine Serum Albumin (Low Endotoxin,Fatty acid free)  (Synonyms: Albumin bovine serum (Low Endotoxin,Fatty acid free); BSA (Low Endotoxin,Fatty acid free))

Bovine Serum Albumin (Low Endotoxin,Fatty acid free) (BSA) is a 583 amino acid globular protein and oligonucleotide binding protein composed of three homologous full α domains. Bovine Serum Albumin (Low Endotoxin,Fatty acid free) (BSA) blocks the overall binding of oligonucleotides to cells. Bovine Serum Albumin (Low Endotoxin,Fatty acid free) (BSA) regulates the development of hamster embryos and induces arthritis^[1][2][3][4].

Bovine Serum Albumin (Low Endotoxin,Fatty acid free) (1%，加到培养基；2 h) 作为主要的结合寡核苷酸细胞表面蛋白可阻断寡核苷酸与 HL60 细胞的整体结合^[2]。
Bovine Serum Albumin (Low Endotoxin,Fatty acid free) (3 mg/mL) 对 hamster 2 细胞胚胎体外发育表现出不同的影响，其中一些批次 (BSA-2 和 BSA-3) 刺激发育，而一些批次 (BSA-1 和 BSA-4) 抑制发育^[3]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Bovine Serum Albumin (Low Endotoxin,Fatty acid free) (免疫：1.5 mL 的 5 mg/mL BSA；攻击：0.5 mL 30% BSA；第 -17 天免疫，第 0 天攻击）可诱发兔子关节炎^[4]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

9048-46-8

固体

Light yellow to khaki

牛血清白蛋白（细胞培养，内毒素<0.01EU/mg）

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Holm NK, et al. Aggregation and fibrillation of bovine serum albumin. Biochim Biophys Acta. 2007 Sep;1774(9):1128-38.  [Content Brief]

  [2]. Geselowitz DA, et al. Bovine serum albumin is a major oligonucleotide-binding protein found on the surface of cultured cells. Antisense Res Dev. 1995 Fall;5(3):213-7.  [Content Brief]

  [3]. McKiernan SH, et al. Different lots of bovine serum albumin inhibit or stimulate in vitro development of hamster embryos. In Vitro Cell Dev Biol. 1992 Mar;28A(3 Pt 1):154-6.  [Content Brief]

  [4]. Sharma ML, et al. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol. 1989;11(6):647-52.  [Content Brief]